Join us for an informative webinar about hereditary hemorrhagic telangiectasia (HHT). The webinar is being run by Cure HHT and will introduce an upcoming clinical trial evaluating whether an investigational medication has the potential to treat HHT. During this session, HHT expert Dr. Hanny Al-Samkari will clearly explain the goals of this clinical trial and who can take part. You’ll also have the opportunity to ask questions anonymously. Register here or using the form provided below.